A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...

"I was 46 when I was diagnosed, I remember it was my birthday." ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

A prostate cancer diagnosis turned life upside down for Lisburn man Stuart Rainey, bringing fear, uncertainty and countless ...

A Northern Ireland man who received a “devastating” prostate cancer diagnosis on his 46th birthday is encouraging others to ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Patches used during the menopause could also be used to help treat a type of prostate cancer, a new study has found.

High comorbidity as a predictor of poorer survival and ARPI efficacy in metastatic prostate cancer. Real-world characteristics of long-term survivors with metastatic castration-resistant prostate ...

An intra-patient contemporaneous comparison of 18F-piflufolastat and 18F-flotufolastat urinary radioactivity and local and pelvic region detection rates in men with low prostate-specific antigen ...

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby.

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...